Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7785 - 7792 of 12086 results
Big Summary Judgment Win for Hospital Defending $300M Exclusive Dealing Antitrust Suit
October 5, 2016| Advisory| Viewpoint
Massachusetts Outlook: The Remainder of 2016 and Beyond
October 4, 2016| Alert| Viewpoint
First Circuit Affirms US Park Service Designation of Long Wharf Pavilion Area for Public Recreational Use
October 4, 2016| Alert| Viewpoint
Medical Marijuana in Massachusetts – DPH Proposes Amendments to Regulations
October 4, 2016| Blog| Viewpoint
Think Before You Settle: Protegrity Teaches Timing is Important When Negotiating Settlement Agreements
October 4, 2016| Blog| Viewpoint
Three Steps to the Right Cloud for Your Business
October 4, 2016| Blog| Viewpoint
New California Law Will Require Online Entertainment Database Sites to Remove Age-Based Information
October 3, 2016| Blog| Viewpoint
U.S. Supreme Court Denies Redskins' Petition to Join SLANTS Case
October 3, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|